LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | ||||||||||
Net income from continuing operations | 255.51%1.23T | 103.31%10.47B | 126.49%209.22B | 1,142.09%328.9B | 232.34%985.48B | -125.59%-788.96B | 89.79%-316.19B | 45.99%-789.8B | 98.51%-31.56B | -1,358.56%-744.68B |
Deferred tax | -85.20%8.54B | 53.74%215.23B | -147.22%-151.42B | -262.76%-535.17B | 14.83%186.03B | -88.51%57.73B | 171.38%140B | -45.89%320.67B | -2,147.02%-147.53B | 25.99%162.01B |
Other non cash items | 84.06%196.93B | -71.76%28.85B | 34.45%765.11B | 109.53%216.78B | 193.78%339.16B | -50.91%107B | -22.70%102.18B | 2.00%569.05B | 4.66%103.46B | -42.89%115.45B |
Change In working capital | -144.01%-60.14B | -39.00%6.8B | 101.31%13.29B | -148.02%-148.64B | -77.02%14.13B | 139.18%136.64B | 101.67%11.15B | -194.01%-1.02T | 88.73%-59.93B | -53.45%61.49B |
-Change in receivables | 63.09%-89.61B | -28.67%87.86B | 7.86%-476.51B | -35.36%-153.73B | 28.53%-203.16B | -89.74%-242.79B | 1,330.45%123.16B | -27.28%-517.16B | -54.52%-113.57B | 14.49%-284.24B |
-Change in inventory | -87.05%-11.46B | -1,145.91%-27.52B | 128.72%5.44B | 128.25%21.48B | -492.46%-12.55B | 82.43%-6.12B | -20.78%2.63B | -62.86%-18.93B | -39.41%9.41B | 112.68%3.2B |
-Change in other current assets | -2,511.54%-161.38B | -1,018.05%-120.01B | -210.92%-231.5B | -1,128.72%-85.89B | -681.63%-165.38B | -87.44%6.69B | -88.98%13.07B | -90.40%208.7B | -96.95%8.35B | -69.26%28.43B |
-Change in other current liabilities | 28.41%215.96B | 253.39%205.25B | 134.59%390.14B | -34.16%11.74B | 219.75%152.13B | 143.42%168.18B | 109.20%58.08B | -16.22%-1.13T | 102.23%17.83B | -643.11%-127.04B |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -14.86%222.5B | 75.08%-43.01B | -66.20%250.55B | 513.16%100.84B | -64.01%60.94B | -36.98%261.34B | -222.56%-172.57B | -72.80%741.29B | -94.80%16.45B | -48.80%169.33B |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | ||||||||||
Capital expenditure reported | ---- | ---- | ---- | ---- | 0.61%-156.02B | 1.53%-169.86B | -12.36%-191.18B | ---- | ---- | -1.01%-156.98B |
Net PPE purchase and sale | ---- | ---199.73B | 1.76%-622.61B | ---- | ---- | ---- | ---- | 24.11%-633.77B | ---- | ---- |
Net business purchase and sale | -568.29%-210.26B | 25.75%117.2B | 1,282.61%96.76B | --0 | 400.30%35.01B | ---31.46B | --93.21B | -95.11%7B | --0 | 1,026.89%7B |
Net investment purchase and sale | 117.83%54.11B | 3.29%-164.72B | -118.74%-123.35B | 1,134.70%81.91B | 37.46%268.48B | -337.98%-303.4B | -149.60%-170.33B | 129.49%658.26B | 94.18%-7.92B | 131.73%195.31B |
Net other investing changes | 99.78%79.57B | -137.23%-97.37B | -96.81%13.95B | -56.46%97.94B | -166.21%-82.77B | 33.51%39.83B | -171.72%-41.04B | 835.74%437B | 192.64%224.93B | 215.88%125.01B |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 62.74%-171.24B | -7.31%-330.29B | -253.67%-841.46B | -7.88%77.72B | -179.10%-151.8B | -3,004.47%-459.59B | -207.58%-307.79B | 118.14%547.58B | 148.18%84.37B | 121.64%191.92B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | ||||||||||
Net issuance payments of debt | 102.66%21.5B | -96.30%31.6B | -92.60%207.78B | -97.97%28.01B | -82.87%132.68B | -124.17%-807.46B | -15.55%854.55B | -3.50%2.81T | 83.88%1.38T | 90.21%774.53B |
Net common stock issuance | -7,689,500.00%-153.79B | 0.00%-2M | 100.00%-8M | -33.33%-4M | 100.00%-4M | 100.00%2M | 100.00%-2M | -75.22%-1.06T | 100.00%-3M | -653.19%-532.35B |
Cash dividends paid | 19.14%-583M | -0.67%-31.63B | 8.38%-64.36B | 17.22%-149M | 5.37%-32.06B | 18.99%-721M | 10.95%-31.42B | 7.39%-70.24B | -15.38%-180M | 9.63%-33.88B |
Net other financing activities | -261.95%-523.93B | -280.75%-350.43B | 73.25%-250.29B | -28.68%-319.95B | 49.22%-161.83B | 534.52%323.53B | 68.69%-92.04B | 5.41%-935.68B | -245.61%-248.64B | -612.97%-318.67B |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -47.10%-797.61B | -202.70%-543.84B | -416.54%-606.22B | -132.01%-341.64B | 15.34%-251.91B | 28.11%-542.23B | 201.02%529.57B | -68.20%191.52B | 266.57%1.07T | -625.74%-297.55B |
Net cash flow | ||||||||||
Beginning cash position | -24.84%5.5T | -10.66%6.19T | 33.97%6.93T | 6.67%6.16T | 13.96%6.71T | 20.52%7.32T | 33.97%6.93T | 10.86%5.17T | 25.10%5.78T | 15.57%5.89T |
Current changes in cash | -0.79%-746.35B | -1,964.10%-917.14B | -180.87%-1.2T | -113.96%-163.08B | -638.16%-342.78B | -108.97%-740.48B | -91.84%49.2B | 379.07%1.48T | 170.06%1.17T | 112.75%63.69B |
Effect of exchange rate changes | -309.08%-276.28B | -42.60%196.18B | 78.36%491.87B | 1,138.78%219.27B | -17.19%-201.33B | -22.20%132.14B | 14.38%341.79B | 39.79%275.77B | -117.94%-21.11B | -788.86%-171.8B |
End cash Position | -33.27%4.48T | -24.84%5.5T | -10.66%6.19T | -10.66%6.19T | 6.67%6.16T | 13.96%6.71T | 20.52%7.32T | 33.97%6.93T | 33.97%6.93T | 25.10%5.78T |
Free cash flow | -59.93%36.65B | 33.27%-242.73B | -446.02%-372.07B | 96.00%-4.71B | -869.86%-95.08B | -62.23%91.48B | -1,139.33%-363.76B | -94.31%107.53B | -168.45%-117.69B | -92.96%12.35B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |